Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cold Spring Harbor Perspectives in Biology|June 22, 2011
Heparan sulfate proteoglycansStephane Sarrazin, William C Lamanna, Jeffrey D Esko
The Journal of Biological Chemistry|January 4, 2011
Secondary storage of dermatan sulfate in Sanfilippo diseaseWilliam C Lamanna, Roger Lawrence, Stéphane Sarrazin, et al.
The Journal of Biological Chemistry|August 9, 2008
Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signalingWilliam C Lamanna, Marc-André Frese, Martina Balleininger, et al.
The Journal of Biological Chemistry|August 12, 2009
Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domainMarc-André Frese, Fabian Milz, Marina Dick, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 31, 2016
Identification of Low-Level Product-Related Variants in Filgrastim Products Presently Available in Highly Regulated MarketsAnna Hausberger, William C Lamanna, Martin Hartinger, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 28, 2017
The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusionWilliam C Lamanna, Katharina Heller, Daniel Schneider, et al.
Journal of Biotechnology|March 6, 2007
The heparanome--the enigma of encoding and decoding heparan sulfate sulfationWilliam C Lamanna, Ina Kalus, Michael Padva, et al.
Expert Opinion on Biological Therapy|December 30, 2017
Maintaining consistent quality and clinical performance of biopharmaceuticalsWilliam C Lamanna, Johann Holzmann, Hillel P Cohen, et al.
The Journal of Biological Chemistry|September 7, 2012
A genetic model of substrate reduction therapy for mucopolysaccharidosisWilliam C Lamanna, Roger Lawrence, Stéphane Sarrazin, et al.
Nature Chemical Biology|January 11, 2012
Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidosesRoger Lawrence, Jillian R Brown, Kanar Al-Mafraji, et al.
Pageof 2